CHI3L1 and breast cancer: In breast cancer, YKL-40 may support cancer progression and facilitate angiogenesis, as experimental knock-down of YKL-40 in tumorigenic breast epithelial cell line D492HER2 resulted in reduced migration and invasion as well as reduced ability to induce angiogenesis in vitro (96).